American Psychiatric Association: Diagnostic and Statistical Manual of Mental Disorders, 5th ed. Arlington, VA: American Psychiatric Association, 2013.
2.
ArangoC, GiráldezM, Merchán-NaranjoJ, BaezaI, Castro-FornielesJ, AldaJA, Martínez-CantareroC, MorenoC, de AndrésP, CuerdaC, de la SernaE, CorrellCU, FraguasD, ParelladaM: Second-generation antipsychotic use in children and adolescents: A six-month prospective cohort study in drug-naïve patients. J Am Acad Child Adolesc Psychiatry, 53:1179–1190,1190.e1–e4, 2014.
3.
HasnainM, ViewegWV, HowlandRH, KogutC, Breden CrouseEL, KoneruJN, HancoxJC, DigbyGC, BaranchukA, DeshmukhA, PandurangiAK: Quetiapine, QTc interval prolongation and torsade de pointes: A review of case reports. Ther Adv Psychopharmacol, 4:130–138, 2014.
LeeSS, HumphreysKL, FloryK, LiuR, GlassK: Prospective association of childhood attention-deficit/hyperactivity disorder (ADHD) and substance use and abuse/dependence: A meta-analytic review. Clin Psychol Rev, 31:328–341, 2011.
8.
MurphyD, BaileyK, StoneM, WirshingWC: Addictive potential of quetiapine. Am J Psychiatry, 165:918, 2008.
9.
OlfsonM, BlancoC, LiuSM, WangS, CorrellCU: National trends in the office-based treatment of children, adolescents, and adults with antipsychotics. Arch Gen Psychiatry, 69:1247–1256, 2012.
PintaER, TaylorRE: Quetiapine addiction?. Am J Psychiatry, 164:174–175, 2007.
12.
SansoneRA, SansoneLA: Is seroquel developing an illicit reputation for misuse/abuse?. Psychiatry (Edgmont), 7:13–16, 2010.
13.
SchatzbergAF, KennethTN, NemeroffCB, MillerLM (eds): Essentials of Clinical Psychopharmacology, 3rd ed. Arlington, VA: American Psychiatric Publishing; 2013.
14.
SimonV, van WinkelR, De HertM: Are weight gain and metabolic side effects of atypical antipsychotics dose dependent? A literature review. J Clin Psychiatry, 70:1041–1050, 2009.
